119 related articles for article (PubMed ID: 38421916)
1. Microfluidic nanoprecipitation of PEGylated PLGA nanoparticles with rapamycin and performance evaluation.
Guo J; Dai W; Wu W; Zhuang S; Zhang H; Cen L
J Biomater Sci Polym Ed; 2024 Jun; 35(8):1197-1213. PubMed ID: 38421916
[TBL] [Abstract][Full Text] [Related]
2. Modulation of immunosuppressive effect of rapamycin via microfluidic encapsulation within PEG-PLGA nanoparticles.
Wu W; Liu R; Guo J; Hu Z; An C; Zhang Y; Liu T; Cen L; Pan Y
J Biomater Appl; 2024 Feb; 38(7):821-833. PubMed ID: 38145897
[TBL] [Abstract][Full Text] [Related]
3. Oligo(Lactic Acid)
Tam YT; Repp L; Ma ZX; Feltenberger JB; Kwon GS
Pharm Res; 2019 Mar; 36(5):70. PubMed ID: 30888509
[TBL] [Abstract][Full Text] [Related]
4. Thermosensitive poly-(d,l-lactide-co-glycolide)-block-poly(ethylene glycol)-block-poly-(d,l-lactide-co-glycolide) hydrogels for multi-drug delivery.
Cho H; Kwon GS
J Drug Target; 2014 Aug; 22(7):669-77. PubMed ID: 24964052
[TBL] [Abstract][Full Text] [Related]
5. Adriamycin release from poly(lactide-coglycolide)-polyethylene glycol nanoparticles: synthesis, and in vitro characterization.
Davaran S; Rashidi MR; Pourabbas B; Dadashzadeh M; Haghshenas NM
Int J Nanomedicine; 2006; 1(4):535-9. PubMed ID: 17722284
[TBL] [Abstract][Full Text] [Related]
6. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
Rafiei P; Haddadi A
Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
[TBL] [Abstract][Full Text] [Related]
7. Development and characterization of folate anchored Saquinavir entrapped PLGA nanoparticles for anti-tumor activity.
Singh R; Kesharwani P; Mehra NK; Singh S; Banerjee S; Jain NK
Drug Dev Ind Pharm; 2015; 41(11):1888-901. PubMed ID: 25738812
[TBL] [Abstract][Full Text] [Related]
8. Prevention of Oxidized Low Density Lipoprotein-Induced Endothelial Cell Injury by DA-PLGA-PEG-cRGD Nanoparticles Combined with Ultrasound.
Li Z; Huang H; Huang L; Du L; Sun Y; Duan Y
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28406431
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional nanoplatform based on star-shaped copolymer for liver cancer targeting therapy.
Gong X; Zheng Y; He G; Chen K; Zeng X; Chen Z
Drug Deliv; 2019 Dec; 26(1):595-603. PubMed ID: 31195837
[TBL] [Abstract][Full Text] [Related]
10. Polysaccharide-modified nanoparticles with intelligent CD44 receptor targeting ability for gene delivery.
Lin WJ; Lee WC
Int J Nanomedicine; 2018; 13():3989-4002. PubMed ID: 30022822
[TBL] [Abstract][Full Text] [Related]
11. Folic acid-decorated and PEGylated PLGA nanoparticles for improving the antitumour activity of 5-fluorouracil.
El-Hammadi MM; Delgado ÁV; Melguizo C; Prados JC; Arias JL
Int J Pharm; 2017 Jan; 516(1-2):61-70. PubMed ID: 27825867
[TBL] [Abstract][Full Text] [Related]
12. Preparation, evaluation, and
Pan X; Liu S; Ju L; Xi J; He R; Zhao Y; Zhuang R; Huang J
Drug Dev Ind Pharm; 2020 Nov; 46(11):1889-1897. PubMed ID: 32975456
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor alpha blocking peptide loaded PEG-PLGA nanoparticles: preparation and in vitro evaluation.
Yang A; Yang L; Liu W; Li Z; Xu H; Yang X
Int J Pharm; 2007 Feb; 331(1):123-32. PubMed ID: 17097246
[TBL] [Abstract][Full Text] [Related]
14. Anti-EGFR-mAb and 5-Fluorouracil Conjugated Polymeric Nanoparticles for Colorectal Cancer.
Bhattacharya S
Recent Pat Anticancer Drug Discov; 2021; 16(1):84-100. PubMed ID: 33349222
[TBL] [Abstract][Full Text] [Related]
15. Development and characterization of hyaluronic acid modified PLGA based nanoparticles for improved efficacy of cisplatin in solid tumor.
Alam N; Koul M; Mintoo MJ; Khare V; Gupta R; Rawat N; Sharma PR; Singh SK; Mondhe DM; Gupta PN
Biomed Pharmacother; 2017 Nov; 95():856-864. PubMed ID: 28903181
[TBL] [Abstract][Full Text] [Related]
16. On the synthesis of mucus permeating nanocarriers.
Bourganis V; Karamanidou T; Samaridou E; Karidi K; Kammona O; Kiparissides C
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):239-49. PubMed ID: 25661586
[TBL] [Abstract][Full Text] [Related]
17. Ascorbic acid tethered polymeric nanoparticles enable efficient brain delivery of galantamine: An in vitro-in vivo study.
Gajbhiye KR; Gajbhiye V; Siddiqui IA; Pilla S; Soni V
Sci Rep; 2017 Sep; 7(1):11086. PubMed ID: 28894228
[TBL] [Abstract][Full Text] [Related]
18. Andrographolide-loaded PLGA-PEG-PLGA micelles to improve its bioavailability and anticancer efficacy.
Zhang J; Li Y; Gao W; Repka MA; Wang Y; Chen M
Expert Opin Drug Deliv; 2014 Sep; 11(9):1367-80. PubMed ID: 24935153
[TBL] [Abstract][Full Text] [Related]
19. Surface-modified PLGA nanoparticles with PEG/LA-chitosan for targeted delivery of arsenic trioxide for liver cancer treatment: Inhibition effects enhanced and side effects reduced.
Song X; Wang J; Xu Y; Shao H; Gu J
Colloids Surf B Biointerfaces; 2019 Aug; 180():110-117. PubMed ID: 31030022
[TBL] [Abstract][Full Text] [Related]
20. Nano-encapsulated metformin-curcumin in PLGA/PEG inhibits synergistically growth and hTERT gene expression in human breast cancer cells.
Farajzadeh R; Pilehvar-Soltanahmadi Y; Dadashpour M; Javidfar S; Lotfi-Attari J; Sadeghzadeh H; Shafiei-Irannejad V; Zarghami N
Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):917-925. PubMed ID: 28678551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
